Thermochemotherapy of a human salivary adenocarcinoma cell line

Oncol Rep. 2002 Mar-Apr;9(2):365-9.

Abstract

We report on thermochemotherapy in a human salivary gland adenocarcinoma cell line. Hyperthermia reduced the survival rate to 50 and 20% by heating at 43 degrees C for 40 and 60 min, respectively, and is by itself useful in human salivary gland carcinoma treatment. Adriamycin, cisplatin, and mitomycin C can possible be used clinically, while bleomycin and 5-fluorouracil cannot, to treat this carcinoma. The optimal temperature was considered to be 41 degrees C in adriamycin, 42 degrees C in cisplatin, 37 degrees C in mitomycin C, and 42 degrees C in bleomycin in the thermochemotherapy. Thermochemotherapy is a useful tool in the treatment of human salivary gland carcinoma cells, but it is necessary to select the best anticancer drugs and the optimal temperature for optimal success using this treatment.

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy*
  • Antineoplastic Agents / therapeutic use*
  • Bleomycin / therapeutic use
  • Cell Survival / drug effects
  • Cisplatin / therapeutic use
  • Combined Modality Therapy
  • Doxorubicin / therapeutic use
  • Fluorouracil / therapeutic use
  • Humans
  • Hyperthermia, Induced*
  • Mitomycin / therapeutic use
  • Salivary Gland Neoplasms / pathology
  • Salivary Gland Neoplasms / therapy*
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / pathology

Substances

  • Antineoplastic Agents
  • Bleomycin
  • Mitomycin
  • Doxorubicin
  • Cisplatin
  • Fluorouracil